Roche blueprints a $466M expansion in China

Roche ($RHHBY) is planning to make a major splash in China, looking to spend 450 million Swiss francs ($466.2 million) to build a diagnostics operation in Suzhou. The new facility will employ more than 600 people once it comes online in 2018, Roche said, focusing on manufacturing diagnostic tests for the growing Asian market. The news comes weeks after the Swiss giant unveiled a plot to spend $1.8 billion on a new research center at its Basel headquarters. More

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.